Paclitaxel
|
Antineoplastic and antimicrotubule |
Suppresses microtubule dynamics by binding to β-tubulin subunits of microtubule and thereby inhibiting spindle function. |
0.00126–12.3 µM |
[123] |
Vincristine
|
Antileukemic, antilymphoma, antineuroblastoma, and antisarcoma |
Inhibits mitosis at the metaphase stage by interacting with tubulin; interferes with amino acids, cyclic AMP, glutathione metabolism, and calmodulin-dependent Ca2+-transport ATPase activity. |
0.00126–1.01e + 3 µM |
[123] |
Camptothecin
|
Antitopoisomerase and anti-HIV |
Causes DNA damage by binding to topoisomerase I and the DNA complex forming a ternary complex, stabilizing it, and preventing DNA re-ligation resulting in apoptosis. |
0.00214–62.3 µM |
[21] |
Rohitukine
|
Anti-inflammatory, anti-fertility, anti-implantation, anti-cancer, and immuno-modulatory |
Triggers apoptosis in lung cancer cells. |
0.3–7.3 μM |
[28] |
Strychnine
|
Neurotoxic, pesticidal, and rodenticidal |
Acts as an antagonist of glycine (an inhibitory neurotransmitter) and acetylcholine receptors, thereby preventing inhibitory signals and activating motor neurons in the spinal cord, resulting into spastic muscle contraction. |
64–92 nM |
[124] |
Ephedrine
|
Promotes short-term weight loss, decreases motion sickness, possesses a cardiac stimulant, hyperglycaemic, hypertensive, bronchodilator |
Indirectly stimulates the adrenergic receptor system by increasing the activity of norepinephrine at the postsynaptic α and β receptors. Acts as a CNS stimulant, due to its ability to cross the blood-brain barrier. |
124 μM |
[125] |
Colchicine
|
Anti-gout, anti-inflammation, and treats familial Mediterranean fever |
Inhibits mitosis by inhibiting microtubule polymerization; inhibits proinflammatory mechanisms and increases anti-inflammatory mediators; inhibits neutrophil motility and activity, interferes with superoxide formation, and thereby inhibits or prevents gout inflammation. |
3–300 nM |
[35] |
Vasicine
|
Bronchodilator, mucolytic, antitussive, antibacterial, cytotoxic, abortifacient, and uterotonic |
Acts as an acetylcholinesterase inhibitor and a butyrylcholinesterase inhibitor. |
125 μM |
[126,127] |
Reserpine
|
Anti-hypertensive and anti-psychotic |
Interferes with the sequestering of neurotransmitters into storage vesicles located in the presynaptic neuron by inhibiting their ATP/Mg2+ pump, causing a reduction in catecholamines, thereby causing antihypertensive effects. |
1.7–2.8 μM |
[128] |
Ajmalicin
|
Anti-hypertensive |
Acts as α1-adrenergic receptor antagonist and shows hypotensive effects. |
3.5–5.44 μM |
[11] |
Tetrandrine
|
Anti-inflammatory, immunologic, anti-allergenic, and anti-tumour; used for treating Ebola virus infection in mice |
Acts as a calcium-channel blocker, inhibits the degranulation of mast cells. |
11.3 μM |
[129] |
Morphine
|
Analgesic and CNS stimulant |
Acts as agonists for mu and kappa opioid receptors, on the ventral tegmental area of the brain; agonist of the delta-opioid receptor in the nucleus accumbens and activates the morphine reward pathway. |
1–8.8 mM |
[37] |
Codeine
|
Analgesic, antidiarrheal, and antitussive |
Acts as agonist for mu opioid receptors involved in the transmission of pain throughout the body and central nervous system. |
60 μM |
[130] |
Papaverine
|
Vasodilatory and antispasmodic |
Shows direct vasodilating action on cerebral blood vessels, increases cerebral blood flow and decreases cerebral vascular resistance. |
2–37 μM |
[6] |
Berberine
|
Antimicrobial, antitumor, anti-hyperglycemic, antimalarial, and anti-inflammation; Alzheimer’s disease treatment |
Lowers cholesterol through LDL-receptor-mediated liver LDL cholesterol clearance, promotes LDL-receptor expression through the proprotein convertase subtilisin/kexin type 9 (PCSK9)-LDL-receptor pathway. |
0.1–25 µM |
[131] |
Scopolamine
|
Depressant action on sympathetic nervous system; possesses mydriatic, spasmolytic, and local anesthetic effects; treats motion sickness, postoperative nausea, and vomiting |
Acts as a non-selective competitive inhibitor of M1-M5 mAChRs (G-protein-coupled muscarinic acetylcholine receptors), shows anticholinergic effect, and alters signalling through CNS associated with vomiting. |
928 µM |
[72] |
Piperine
|
Presents hemo-preventive, anti-carcinogenic, antioxidant, anti-inflammatory, anticarcinogenic, stimulatory, hepatoprotective, antihyperlipidemia, anti-asthmatic activities; gastro-intestinal stimulant, and appetite stimulant |
Affects the plasma concentrations of P-glycoprotein in the (P-gp)-mediated transport of drugs and metabolizes enzyme CYP3A4 substrates in humans; lowers endogenous UDP-glucuronic acid contents and inhibits transferase activity, thereby modifying the rate of glucuronidation. |
1–34 μM |
[132] |
Lupinine
|
Insecticidal |
Reversible inhibitor of acetylcholinesterases; possesses a binding affinity for muscarinic and nicotinic acetylcholine receptors. |
712 μM |
[133] |
Swainsonine
|
Chemotherapeutic |
Acts as a golgi α-mannosidase II inhibitor |
34 nM |
[134] |
Skimmianine
|
Analgesic, antispastic, sedative, and anti-inflammatory |
Suppresses TNF-α and IL-6 gene transcription, inhibits the production of NO, prostaglandin E2, and superoxide anions. |
8.6 μg/mL |
[20] |
Theobromine
|
Antitumor, bronchorelaxater, and antitussive |
Acts as antagonist to adenosine-receptors within the plasma membrane of virtually every cell, which further promotes neurotransmitter release. |
2500 µM |
[135] |
Caffeine
|
Autonomous nervous system stimulant, anti-inflammation; improves cognitive performance |
Inhibits the activity of nucleotide phosphodiesterase enzymes, regulates calcium handling in cells, and participates in adenosine receptor antagonism, stimulating inotropic effects in the heart. |
500–1000 μM |
[136] |
Nicotine
|
Antiherbivore, insecticide, teratogenic, addictive, stimulant, and anxiolytic effects; treatment of nicotine dependence |
Acts as an agonist/antagonist of certain nicotinic acetylcholine receptors, binding with receptors leading to depolarization, activating voltage-gated calcium channels. |
0.5–20 nM |
[137,138] |
Veratridine
|
Inhibitor of sodium channel inactivation and neurotoxic |
Depolarizes cells by affecting sodium channels, can activate Nav 1.8 along with additional Nav channels; enhances protein tyrosine phosphorylation; can turn the membrane potential to a more positive one and can also modify the effect of progesterone on (a2+)i and sperm membrane potential. |
27–84 µM |
[139] |
Aconitine
|
Analgesic, blood coagulant, anti-inflammatory, cardiotoxic, and neurotoxic |
Interacts with voltage-dependent sodium-ion channels, binds to the channel at the neurotoxin binding site 2 on the α-subunit, suppressing the conformational change in the sodium-ion channel from an active state to an inactive state. |
10–20 µM |
[140] |
Hygrine
|
Sedative, hypnotic laxative, and diuretics |
Not known. |
Not reported |
[31] |
Boldine
|
Antioxidant, antipyretic, anti-inflammation, hepatoprotectant, cytoprotectant, and neuroprotectant |
Acts as an α-adrenergic antagonist in vascular tissues; it can cross the blood-brain barrier exhibiting neuroprotective effects. |
8.5 µM |
[141] |
Atropine
|
Anticholinergic, antispasmodic, and antimuscarinic |
Binds and inhibits muscarinic acetylcholine receptors, producing anticholinergic effects. |
2–55 µM |
[32] |
Capsaicin
|
Anti-obesity, antifungal action, and chemical irritant; treating peripheral neuropathy, psoriasis, and non-allergic rhinitis |
Induces a topical hypersensitivity reaction on the skin by carrying out the “defunctionalization” of nociceptor fibers. Pain mechanism is due to temporary loss of membrane potential, inability to transport neurotrophic factors, and the reversible retraction of epidermal and dermal nerve fiber terminals. |
50 μM |
[142] |
α-Solanine
|
Antiallergic, anti-inflammation, antipyretic, and anti-carcinogen; treating gastrointestinal and neurological disorders |
Inhibits cholinesterase activity, disrupts cell membranes; opens the potassium channels of the mitochondria increasing their membrane potential, followed by the transport of Ca2+ from mitochondria into the cytoplasm leading to the an increased concentration of Ca2+ in the cytoplasm triggering cell damage and apoptosis. |
32.18 μM |
[143] |
α-Tomatine
|
Anti-leukemia, fungicide, antimicrobial, and insecticide |
Causes the disruption of cellular membranes and the inhibition of acetylcholinesterase; stimulates the immune system by participation in a sequence of respiratory burst destroying bacteria. |
7–10 μM |
[144] |
Jatrorrhizine
|
Antibacterial and antifungal |
Blocks α-1 and α-2 adrenoreceptors and monoamine oxidase A and B. |
4–62 μM |
[98] |
Palmatine
|
Antimicrobial, hypoglycemic, antiarrhythmic, and antioxidant |
Intercalates with nucleic acids; induces apoptosis; inhibits proliferation. |
0.07–22 µM |
[145] |
Quinine
|
Antimalaria, mild antipyretic, and analgesic |
Interferes with a parasite’s ability to break down and digest hemoglobin, leading to starvation in parasites. |
13.4 µM |
[146] |
Cytisine
|
Teratogenic |
Partial agonist of α4-β2 nicotinic acetylcholine receptors; causes a reduction in the effects of nicotine on dopamine release in the mesolimbic system when given alone, while simultaneously attenuates nicotine withdrawal symptoms accompanying cessation attempts. |
27.3 nM |
[147] |